TY  - JOUR
AU  - Yu, Lian
AU  - Xu, Jianlin
AU  - Qiao, Rong
AU  - Zhong, Hua
AU  - Brueckl, Wolfgang M.
AU  - Zhong, Runbo
PY  - 2023
TI  - Comparative efficacy and safety of multitarget angiogenesis inhibitor combined with immune checkpoint inhibitor and nivolumab monotherapy as second-line or beyond for advanced lung adenocarcinoma in driver-negative patients: a retrospective comparative cohort study
JF  - Translational Lung Cancer Research; Vol 12, No 5 (May 31, 2023): Translational Lung Cancer Research
Y2  - 2023
KW  - 
N2  - 
UR  - https://tlcr.amegroups.org/article/view/75412